In general, the invention features antibodies specific for PrPSc and diagnostic, therapeutic, and decontamination uses thereof. The invention also features synthetic peptides useful as immunogens for generating antibodies specific for PrPSc and therapeutic for the treatment of prion diseases.


< Sulphur dioxide generators

< Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists

> Canine herpes virus alpha transinducing factor nucleic acid molecules

> Water-soluble or water-dispersible graft polymers, their preparation and use

~ 00259